
Vol. 135, No. 4, 2004
Free Abstract
Article (Fulltext)
Article (PDF 200 KB)
Original Paper
Staphylococcal Enterotoxin-B-Mediated Stimulation of Interleukin-13 Production as a Potential Aetiologic Factor in Eczema in Infants
H.S. Lehmanna, T. Heatona, D. Mallonb, P.G. Holta
aTelethon Institute for Child Health Research, and Centre for Child Health Research, Faculty of Medicine and Dentistry, The University of Western Australia, bDepartments of Immunology, Fremantle and Princess Margaret Hospitals, Perth, Australia
Address of Corresponding Author
Int Arch Allergy Immunol 2004;135:306-312 (DOI: 10.1159/000082324)
Key Words
- Interleukin-13
- Atopic dermatitis
- Staphylococcal enterotoxin B
Abstract
Background: Staphylococcus aureus colonization has been found in 80-100% of lesional skin from patients with atopic eczema dermatitis syndrome (AEDS) and is thought to have a role in the pathogenesis of the disease. Furthermore, up to 65% of S. aureus from lesional skin has been shown to produce toxigenic superantigens. Methods: Using a cohort of 11 children under 2 years of age diagnosed with AEDS, we isolated peripheral blood mononuclear cells, cultured them with staphylococcal enterotoxin B (SEB) and phytohaemagglutinin, and assessed the cytokine response profiles. Plasma was also collected for immunoglobulin E analysis. In addition, skin and nasal swabs were taken and cultured to determine the presence of SEB-producing S. aureus by polymerase chain reaction (PCR) and reverse passive latex agglutination. Results: We found a significant increase in the production of the SEB-induced cytokines interleukin (IL)-5 and IL-13 in the patient group when compared with non-atopic, healthy controls. For IL-13, there was almost no overlap in the levels between the groups. However, there was no correlation between SEB-induced IL-13 and disease severity. This difference was not seen when heat-inactivated S. aureus was used to stimulate the cells. Conclusions: IL-13 is an important factor in AEDS development in early childhood, and prophylactic anti-staphylococcal treatment may provide protection from AEDS in atopic individuals. Copyright © 2004 S. Karger AG, Basel
Author Contacts
Correpondence to: Prof. P.G. Holt Division of Cell Biology, Telethon Institute for Child Health Research PO Box 855 West Perth, WA 6872 (Australia) Tel. +61 8 9489 7838, Fax +61 8 9489 7707, E-Mail patrick@ichr.uwa.edu.au
Article Information
Received: May 5, 2004
Accepted after revision: August 18, 2004
Published online: November 24, 2004
Number of Print Pages : 7
Number of Figures : 3, Number of Tables : 1, Number of References : 32 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|